HALOZYME THERAPEUTICS INC shareholders Q2 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 369 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
YOUSIF CAPITAL MANAGEMENT, LLC 67,446$2,432,7770.03%
Dana Investment Advisors, Inc. 16,153$582,6390.03%
First Western Trust Bank 15,795$569,7260.03%
NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC 29,264$1,055,5520.03%
Gotham Asset Management, LLC 35,953$1,296,8250.03%
Retirement Systems of Alabama 169,694$6,120,8630.03%
WCM INVESTMENT MANAGEMENT, LLC 236,368$8,639,2500.03%
HoyleCohen, LLC 8,100$292,1670.03%
AMALGAMATED BANK 86,375$3,1160.02%
Joel Isaacson & Co., LLC 10,462$377,3640.02%
Ensign Peak Advisors, Inc 338,600$12,213,3020.02%
SEI INVESTMENTS CO 393,971$14,210,4560.02%
Engineers Gate Manager LP 18,444$665,2750.02%
Covestor Ltd 922$330.02%
Laird Norton Wetherby Wealth Management, LLC 12,581$453,7970.02%
TOWNSQUARE CAPITAL LLC 36,226$1,306,6730.02%
CSS LLC/IL 10,700$385,9490.02%
SYNOVUS FINANCIAL CORP 60,188$2,170,9760.02%
GABELLI FUNDS LLC 83,738$3,020,4300.02%
Invesco Ltd. 2,476,145$89,314,5510.02%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.